Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
153.1 USD | +0.24% | +3.69% | +7.38% |
Mar. 27 | North American Morning Briefing : Stocks Edge -2- | DJ |
Mar. 26 | The market's a bit of a bore |
Financials (USD)
Sales 2024 * | 7.25B | Sales 2025 * | 7.51B | Capitalization | 19B |
---|---|---|---|---|---|
Net income 2024 * | 397M | Net income 2025 * | 716M | EV / Sales 2024 * | 2.95 x |
Net Debt 2024 * | 2.35B | Net Debt 2025 * | 2.28B | EV / Sales 2025 * | 2.83 x |
P/E ratio 2024 * |
48.3
x | P/E ratio 2025 * |
26.7
x | Employees | 8,700 |
Yield 2024 * |
3.14% | Yield 2025 * |
3.29% | Free-Float | 94.75% |
Latest transcript on The Clorox Company
1 day | +0.24% | ||
1 week | +3.69% | ||
Current month | -0.13% | ||
1 month | -0.24% | ||
3 months | +7.78% | ||
6 months | +19.04% | ||
Current year | +7.38% |
Managers | Title | Age | Since |
---|---|---|---|
Linda Rendle
CEO | Chief Executive Officer | 46 | 02-12-31 |
Kevin Jacobsen
DFI | Director of Finance/CFO | 57 | 94-12-31 |
Michael Ott
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Allan Mackay
BRD | Director/Board Member | 68 | 16-08-14 |
Director/Board Member | 71 | 15-06-30 | |
Director/Board Member | 66 | 15-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 153.1 | +0.24% | 1,136,963 |
24-03-27 | 152.7 | +1.87% | 998,223 |
24-03-26 | 149.9 | -0.39% | 1,165,950 |
24-03-25 | 150.5 | -0.15% | 1,265,975 |
24-03-22 | 150.8 | +2.09% | 2,051,539 |
Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.38% | 19B | |
+10.31% | 25.44B | |
-23.51% | 6.49B | |
+6.41% | 6B | |
+5.96% | 3.44B | |
+3.78% | 2.47B | |
-8.20% | 1.94B | |
+23.63% | 946M | |
+0.64% | 803M | |
-5.58% | 622M |